Correction: Experimental Hematology & Oncology (2023) 12:3 https://doi.org/10.1186/s40164-022-00363-1
In the Funding secion of this article [1], the grant number relating to National Natural Science Foundation of China was given incorrectly as No.8210114078 and should have been No.82103671.
Funding
This work was funded by the National Natural Science Foundation of China (Grant No.82103671).
The original article has been corrected.
Reference
Guo L, Kong D, Liu J, Zhan L, Luo L, Zheng W, Zheng Q, Chen C, Sun S. Breast cancer heterogeneity and its implication in personalized precision therapy. Exp Hematol Oncol. 2023;12:3. https://doi.org/10.1186/s40164-022-00363-1.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Guo, L., Kong, D., Liu, J. et al. Correction: Breast cancer heterogeneity and its implication in personalized precision therapy. Exp Hematol Oncol 13, 7 (2024). https://doi.org/10.1186/s40164-024-00472-z
Published:
DOI: https://doi.org/10.1186/s40164-024-00472-z